Abstract
Colorectal cancer (CRC) represents a global health challenge, with increasing incidence rates necessitating effective early detection and prognostic techniques. Recent research has identified microbial markers vital for CRC diagnostics, including Fusobacterium nucleatum and Escherichia coli. The gut microbiome plays a crucial role in tumor development and treatment approaches, with 15-20% of CRC cases showing significant changes in microbial ecosystems that serve as non-invasive biomarkers for early diagnosis and targeted therapies. Microbes like Bacteroides fragilis and Akkermansia muciniphila are linked to various CRC stages, highlighting their influence in disease progression. High levels of Fusobacterium nucleatum notably increase CRC risk, improving diagnostic precision. These microbial indicators may enhance early detection rates by 30% compared to standard methods, while advantageous taxa potentially boost survival rates by 50%. Ongoing research focuses on examining microbial communities in fecal samples to identify CRC signatures and enhance understanding of the disease.

This publication has 76 references indexed in Scilit: